The longitudinal association between inflammation and incident depressive symptoms in men: The effects of hs-CRP are independent of abdominal obesity and metabolic disturbances

Physiology and Behavior

Volumn 139, Issue , 2015, Pages 328-335

  Tully, Phillip J ^a,b   Baumeister, Harald ^b   Bengel, Jürgen ^b   Jenkins, Alicia ^c   Januszewski, Andrzej ^c   Martin, Sean ^a   Wittert, Gary A ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Abdominal adiposity; Body mass index; C reactive protein; Depression; Inflammation; Interleukin 6; Longitudinal; Metabolic syndrome; Obesity; Tumor necrosis factor alpha

Indexed keywords

C REACTIVE PROTEIN; GLUCOCORTICOID; GLUCOSE; HEMOGLOBIN A1C; INTERLEUKIN 6; NEUROLEPTIC AGENT; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; IL6 PROTEIN, HUMAN;

ABDOMINAL OBESITY; ADULT; ARTICLE; BLOOD SAMPLING; DEPRESSION; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DRUG USE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; OSTEOARTHRITIS; PHYSICAL CAPACITY; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; AGED; BLOOD; INCIDENCE; LONGITUDINAL STUDY; METABOLIC DISEASES; METABOLISM; MIDDLE AGED; OBESITY, ABDOMINAL; PATHOPHYSIOLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; DEPRESSION; HUMANS; INCIDENCE; INFLAMMATION; INTERLEUKIN-6; LONGITUDINAL STUDIES; MALE; METABOLIC DISEASES; MIDDLE AGED; OBESITY, ABDOMINAL; TUMOR NECROSIS FACTOR-ALPHA; WAIST CIRCUMFERENCE;

EID: 84912097018     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2014.11.058     Document Type: Article

References (60)

1. Ng M., Fleming T., Robinson M., Thomson B., Graetz N., Margono C., et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study. Lancet 2013, 2014.
2. Luppino F.S., de Wit L.M., Bouvy P.F., Stijnen T., Cuijpers P., Penninx B.W., et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry 2010, 67:220-229.
3. Valtonen M.K., Laaksonen D.E., Laukkanen J.A., Tolmunen T., Viinamaki H., Lakka H.M., et al. Low-grade inflammation and depressive symptoms as predictors of abdominal obesity. Scand J Public Health 2012, 40:674-680.
4. Cartier A., Cote M., Lemieux I., Perusse L., Tremblay A., Bouchard C., et al. Age-related differences in inflammatory markers in men: contribution of visceral adiposity. Metabolism 2009, 58:1452-1458.
5. Smith M.M., Minson C.T. Obesity and adipokines: effects on sympathetic overactivity. J Physiol 2012, 590:1787-1801.
6. Maes M. Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression. Prog Neuropsychopharmacol Biol Psychiatry 2011, 35:664-675.
7. Leonard B., Maes M. Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci Biobehav Rev 2012, 36:764-785.
8. Dowlati Y., Herrmann N., Swardfager W., Liu H., Sham L., Reim E.K., et al. A meta-analysis of cytokines in major depression. Biol Psychiatry 2010, 67:446-457.
9. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008, 9:46-56.
10. Messay B., Lim A., Marsland A. Current understanding of the bi-directional relationship of major depression with inflammation. Biol Mood Anxiety Disord 2012, 2:4.
11. Dantzer R., Kelley K.W. Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun 2007, 21:153-160.
12. Penninx B.W., Milaneschi Y., Lamers F., Vogelzangs N. Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile. BMC Med 2013, 11:129.
13. van Reedt Dortland A.K., Vreeburg S.A., Giltay E.J., Licht C.M., Vogelzangs N., van Veen T., et al. The impact of stress systems and lifestyle on dyslipidemia and obesity in anxiety and depression. Psychoneuroendocrinology 2013, 38:209-218.
14. Blume J., Douglas S.D., Evans D.L. Immune suppression and immune activation in depression. Brain Behav Immun 2011, 25:221-229.
15. Liu Y., Ho R.C., Mak A. Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. J Affect Disord 2012, 139:230-239.
16. Gimeno D., Kivimaki M., Brunner E.J., Elovainio M., De Vogli R., Steptoe A., et al. Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychol Med 2009, 39:413-423.
17. Deverts D.J., Cohen S., DiLillo V.G., Lewis C.E., Kiefe C., Whooley M., et al. Depressive symptoms, race, and circulating C-reactive protein: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Psychosom Med 2010, 72:734-741.
18. Matthews K.A., Schott L.L., Bromberger J.T., Cyranowski J.M., Everson-Rose S.A., Sowers M. Are there bi-directional associations between depressive symptoms and C-reactive protein in mid-life women?. Brain Behav Immun 2010, 24:96-101.
19. Hamer M., Molloy G.J., de Oliveira C., Demakakos P. Persistent depressive symptomatology and inflammation: to what extent do health behaviours and weight control mediate this relationship?. Brain Behav Immun 2009, 23:413-418.
20. Valkanova V., Ebmeier K.P., Allan C.L. CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies. J Affect Disord 2013, 150:736-744.
21. Hamer M., Batty G.D., Kivimaki M. Risk of future depression in people who are obese but metabolically healthy: the English longitudinal study of ageing. Mol Psychiatry 2012, 17:940-945.
22. Howren M.B., Lamkin D.M., Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 2009, 71:171-186.
23. Bouchard C. BMI, fat mass, abdominal adiposity and visceral fat: where is the beef?. Int J Obes 2007, 31:1552-1553.
24. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112:2735-2752.
25. Stewart J.C., Rand K.L., Muldoon M.F., Kamarck T.W. A prospective evaluation of the directionality of the depression-inflammation relationship. Brain Behav Immun 2009, 23:936-944.
26. Jokela M., Hamer M., Singh-Manoux A., Batty G.D., Kivimaki M. Association of metabolically healthy obesity with depressive symptoms: pooled analysis of eight studies. Mol Psychiatry 2014, 19:910-914.
27. Grant J.F., Martin S.A., Taylor A.W., Wilson D.H., Araujo A., Adams R.J., et al. Cohort Profile: The Men Androgen Inflammation Lifestyle Environment and Stress (MAILES) Study. Int J Epidemiol 2014, 43:1040-1053.
28. Shi Z., Araujo A.B., Martin S., O'Loughlin P., Wittert G.A. Longitudinal changes in testosterone over five years in community-dwelling men. J Clin Endocrinol Metab 2013, 98:3289-3297.
29. Jesudason D.R., Dunstan K., Leong D., Wittert G.A. Macrovascular risk and diagnostic criteria for type 2 diabetes: implications for the use of FPG and HbA(1c) for cost-effective screening. Diabetes Care 2003, 26:485-490.
30. Schneider A.L., Pankow J.S., Heiss G., Selvin E. Validity and reliability of self-reported diabetes in the Atherosclerosis Risk in Communities Study. Am J Epidemiol 2012, 176:743.
31. Okura Y., Urban L.H., Mahoney D.W., Jacobsen S.J., Rodeheffer R.J. Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol 2004, 57:1096-1103.
32. Australian Bureau of Statistics National Health Survey: users' guide 2003, [Canberra, Australia].
33. Radloff L.S. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977, 1:385-401.
34. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961, 4:561-571.
35. Beck A.T., Steer R.A., Garbin M.G. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev 1988, 8:77-100.
36. Rothman K.J. No adjustments are needed for multiple comparisons. Epidemiology 1990, 1:43-46.
37. Babyak M.A. What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models. Psychosom Med 2004, 66:411-421.
38. Tabachnick B.G., Fidell L.S. Using multivariate statistics 2000, Allyn and Bacon, Boston, MA. 4th ed.
39. Daly M. The relationship of C-reactive protein to obesity-related depressive symptoms: a longitudinal study. Obesity (Silver Spring, Md.) 2013, 21:248-250.
40. van den Biggelaar A.H.J., Gussekloo J., de Craen A.J.M., Frölich M., Stek M.L., van der Mast R.C., et al. Inflammation and interleukin-1 signaling network contribute to depressive symptoms but not cognitive decline in old age. Exp Gerontol 2007, 42:693-701.
41. Baune B.T., Smith E., Reppermund S., Air T., Samaras K., Lux O., et al. Inflammatory biomarkers predict depressive, but not anxiety symptoms during aging: the prospective Sydney Memory and Aging Study. Psychoneuroendocrinology 2012, 37:1521-1530.
42. Chocano-Bedoya P.O., Mirzaei F., O'Reilly E.J., Lucas M., Okereke O.I., Hu F.B., et al. C-reactive protein, interleukin-6, soluble tumor necrosis factor α receptor 2 and incident clinical depression. J Affect Disord 2014, 163:25-32.
43. Vetter M.L., Wadden T.A., Vinnard C., Moore R.H., Khan Z., Volger S., et al. Gender differences in the relationship between symptoms of depression and high-sensitivity CRP. Int J Obes (Lond) 2013, 37(Suppl. 1):S38-S43.
44. Au B., Schmitz N. Association of C-reactive protein with metabolic syndrome and depressive symptoms in the English longitudinal study of ageing. J Epidemiol Community Health 2013, 67:e2.
45. Luukinen H., Jokelainen F., Hedberg P. The relationships between high-sensitivity C-reactive protein and incident depressed mood among older adults. Scand J Clin Lab Invest 2010, 70:75-79.
46. Baune B.T., Konrad C., Grotegerd D., Suslow T., Birosova E., Ohrmann P., et al. Interleukin-6 gene (IL-6): a possible role in brain morphology in the healthy adult brain. J Neuroinflammation 2012, 9:125.
47. Vogelzangs N., Duivis H.E., Beekman A.T., Kluft C., Neuteboom J., Hoogendijk W., et al. Association of depressive disorders, depression characteristics and antidepressant medication with inflammation. Transl Psychiatry 2012, 2:e79.
48. Hamer M., Sabia S., Batty G.D., Shipley M.J., Tabak A.G., Singh-Manoux A., et al. Physical activity and inflammatory markers over 10years: follow-up in men and women from the Whitehall II cohort study. Circulation 2012, 126:928-933.
49. Capuron L., Su S., Miller A.H., Bremner J.D., Goldberg J., Vogt G.J., et al. Depressive symptoms and metabolic syndrome: is inflammation the underlying link?. Biol Psychiatry 2008, 64:896-900.
50. Patas K., Penninx B.W.J.H., Bus B.A.A., Vogelzangs N., Molendijk M.L., Elzinga B.M., et al. Association between serum brain-derived neurotrophic factor and plasma interleukin-6 in major depressive disorder with melancholic features. Brain Behav Immun 2014, 36:71-79.
51. Baumeister H., Parker G. Meta-review of depressive subtyping models. J Affect Disord 2012, 139:126-140.
52. Rosmond R., Dallman M.F., Bjorntorp P. Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J Clin Endocrinol Metabol 1998, 83:1853-1859.
53. Bjorntorp P. Do stress reactions cause abdominal obesity and comorbidities?. Obes Rev 2001, 2:73-86.
54. Pasco J.A., Nicholson G.C., Williams L.J., Jacka F.N., Henry M.J., Kotowicz M.A., et al. Association of high-sensitivity C-reactive protein with de novo major depression. Br J Psychiatry 2010, 197:372-377.
55. Milaneschi Y., Corsi A.M., Penninx B.W., Bandinelli S., Guralnik J.M., Ferrucci L. Interleukin-1 receptor antagonist and incident depressive symptoms over 6years in older persons: the InCHIANTI study. Biol Psychiatry 2009, 65:973-978.
56. Hamer M., Batty G.D., Marmot M.G., Singh-Manoux A., Kivimaki M. Anti-depressant medication use and C-reactive protein: results from two population-based studies. Brain Behav Immun 2011, 25:168-173.
57. Almeida O.P., Calver J., Jamrozik K., Hankey G.J., Flicker L. Obesity and metabolic syndrome increase the risk of incident depression in older men: the health in men study. Am J Geriatr Psychiatry 2009, 17:889-898.
58. Chaput J.P., Drapeau V., Hetherington M., Lemieux S., Provencher V., Tremblay A. Psychobiological effects observed in obese men experiencing body weight loss plateau. Depress Anxiety 2007, 24:518-521.
59. Butnoriene J., Bunevicius A., Norkus A., Bunevicius R. Depression but not anxiety is associated with metabolic syndrome in primary care based community sample. Psychoneuroendocrinology 2014, 40:269-276.
60. Grillo C.A., Mulder P., Macht V.A., Kaigler K.F., Wilson S.P., Wilson M.A., et al. Dietary restriction reverses obesity-induced anhedonia. Physiol Behav 2014, 128:126-132.